eGenesis

OverviewSuggest Edit

eGenesis is a life sciences company focused on development and commercialization of engineered organisms for the benefit of human health. The company's technology is based on the next-generation genome engineering tool set, CRISPR. eGenesis' team of scientists and advisers include world recognized leaders in the field of genome engineering and regenerative medicine.
TypePrivate
Founded2014
HQCambridge, MA, US
Websiteegenesisbio.com

Latest Updates

Employees (est.) (Jan 2022)85(+3%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at eGenesis

Julie Sunderland

Julie Sunderland

Director
Paul Sekhri

Paul Sekhri

President & Chief Executive Officer and Director
Ariel Jasie

Ariel Jasie

Chief Business Officer & General Counsel
William Westlin

William Westlin

Executive Vice President, Research & Development
Isaac Ciechanover

Isaac Ciechanover

Director
Lucio Iannone

Lucio Iannone

Director
Show more

eGenesis Office Locations

eGenesis has offices in Cambridge and New York
Cambridge, MA, US (HQ)
300 Tech Square, 300 Technology Square #301
New York, NY, US
Times Square Tower
Show all (2)

eGenesis Financials and Metrics

Summary Metrics

Founding Date

2014

eGenesis total Funding

$265 m

eGenesis latest funding size

$125 m

Time since last funding

a year ago

eGenesis investors

eGenesis's latest funding round in March 2021 was reported to be $125 m. In total, eGenesis has raised $265 m
Show all financial metrics

eGenesis Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

eGenesis Online and Social Media Presence

Embed Graph

eGenesis News and Updates

eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today announced the appointment of accomplished financial executive, Bradford Smith, Chief Financial Officer (CFO) of Homology Medicines, Inc., …

eGenesis Expands Research Collaboration with Leading Academic Medical Center

Collaboration will now include in vivo testing of lead kidney xenotransplant program in addition to pancreatic islet xenotransplant program

eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer

CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs, tissues, and cells, today announced the appointment of Sapna Srivastava, Ph.D., as Chief Financial Officer. Dr. Srivastava joins eGenesis with more than …

eGenesis Announces $125 Million Series C Financing

Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studies Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studies

eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec

Acquisition enables full integration of R&D and production for ongoing and future xenotransplant programs

eGenesis Blogs

eGenesis Announces Research Collaboration with Leading Academic Medical Center

Partnership enables eGenesis’ genome engineering and transgenic production capabilities to conduct in vivo testing of pancreatic islet cell xenotransplants CAMBRIDGE, Mass., November 5, 2020 —  eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe…

eGenesis Appoints Veteran Biotechnology Development Executive, Michael Curtis, Ph.D., as President of Research & Development

CAMBRIDGE, Mass., Sept. 01, 2020 — eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs, tissues, and cells to address the global organ shortage crisis, today announced the appointment of Michael Curtis, Ph.D…

eGenesis Appoints Accomplished Biopharmaceutical Executive, Peter Hanson, DVM, Ph.D., as Chief Operating Officer

CAMBRIDGE, Mass., July 1, 2020 (GLOBE NEWSWIRE) — eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs, tissues, and cells to address the global organ shortage, today announced that Peter Hanson, DVM, Ph.D., …

eGenesis Expands Research Collaboration with Massachusetts General Hospital

Research collaboration will conduct in vivo testing of lead kidney and islet xenotransplant programs and validate platform in other organs CAMBRIDGE, Mass., June 2, 2020 — eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-c…

eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications

NEW YORK & CAMBRIDGE, Mass., Apr. 6, 2020 — eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of safe and effective human-compatible organs to address the global organ shortage, announced that David A. Carmel has been appointed as senior vice …

eGenesis Announces $100 Million Series B Financing

– Financing led by Fresenius Medical Care Ventures – Proceeds will be used to accelerate lead program in kidney xenotransplant into the clinic and progress a range of other xenotransplant programs across solid organ and cell therapy CAMBRIDGE, Mass. – Nov. 7, 2019 – eGenesis, a biotechnology company…
Show more

eGenesis Frequently Asked Questions

  • When was eGenesis founded?

    eGenesis was founded in 2014.

  • Who are eGenesis key executives?

    eGenesis's key executives are Julie Sunderland, Paul Sekhri and Ariel Jasie.

  • How many employees does eGenesis have?

    eGenesis has 85 employees.

  • Who are eGenesis competitors?

    Competitors of eGenesis include TxCell, Diversigen and Life in Genomics.

  • Where is eGenesis headquarters?

    eGenesis headquarters is located at 300 Tech Square, 300 Technology Square #301, Cambridge.

  • Where are eGenesis offices?

    eGenesis has offices in Cambridge and New York.

  • How many offices does eGenesis have?

    eGenesis has 2 offices.